71352 Efficacy of izokibep, a novel interleukin-17A inhibitor, in moderate to severe hidradenitis suppurativa: Week 32 results from a randomized, double-blind, placebo-controlled, multicenter, phase 3 study

Journal of the American Academy of Dermatology 2026

View at publisher
Authors: Kim A. Papp, Falk G. Bechara, Martina L. Porter, Seth B. Forman, Howard L. Sofen, Jacek C. Szepietowski, Benjamin D. Ehst, Antonio Martorell, Shephard Mpofu, Fredrik Y. Frejd, Alexa B. Kimball
DOI: 10.1016/j.jaad.2026.04.781
Cited by: 1

Fields of Study & Subjects

Hidradenitis Suppurativa and Treatments Microscopic Colitis Anorectal Disease Treatments and Outcomes

Publication details

Journal / source
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Volume
95
Issue
1
Pages
AB192–AB192
Publication date
1 July 2026
Language
EN